Literature DB >> 19698757

Single-walled carbon nanotubes activate platelets and accelerate thrombus formation in the microcirculation.

Peter Bihari1, Martin Holzer, Marc Praetner, Janos Fent, Max Lerchenberger, Christoph A Reichel, Markus Rehberg, Susan Lakatos, Fritz Krombach.   

Abstract

OBJECTIVES: Although ambient nanoparticles have been shown to exert prothrombotic effects, manufactured nanoparticles are in this aspect less well investigated. Thus, the aim of this study was to characterize the effects of diesel, titanium dioxide rutile, and single-walled carbon nanotube nanoparticles on (i) platelet activation in vitro and (ii) on macro- and microcirculatory thrombus formation in vivo.
METHODS: Platelet P-selectin expression was measured by flow cytometry after incubation of whole blood with diesel (0.1mg/mL), titanium dioxide (0.1mg/mL) or single-walled nanotubes (0.001-0.1mg/mL). Platelet-granulocyte complexes were analyzed in whole blood and platelet aggregometry was performed with platelet-rich plasma. Upon systemic administration of nanoparticles (1mg/kg) to anesthetized mice, ferric chloride-induced thrombus formation was measured in small mesenteric arteries using in vivo microscopy. In separate experiments, diesel (1mg/kg), titanium dioxide (1mg/kg), or single-walled nanotubes (0.01-1mg/kg) were injected into anesthetized mice and light/dye-induced thrombus formation was investigated in the cremasteric microcirculation.
RESULTS: Diesel and titanium dioxide nanoparticles did not activate platelets or exert prothrombotic effects. In contrast, single-walled nanotubes significantly increased platelet P-selectin expression, the number of platelet-granulocyte complexes, and platelet aggregability in vitro, and reduced the occlusion time in mesenteric arteries as well as in cremasteric arterioles.
CONCLUSION: Our study shows that single-walled carbon nanotubes, but not diesel or titanium dioxide nanoparticles, induce platelet activation in vitro and exert prothrombotic effects in the microcirculation in vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19698757     DOI: 10.1016/j.tox.2009.08.011

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  19 in total

Review 1.  Safe clinical use of carbon nanotubes as innovative biomaterials.

Authors:  Naoto Saito; Hisao Haniu; Yuki Usui; Kaoru Aoki; Kazuo Hara; Seiji Takanashi; Masayuki Shimizu; Nobuyo Narita; Masanori Okamoto; Shinsuke Kobayashi; Hiroki Nomura; Hiroyuki Kato; Naoyuki Nishimura; Seiichi Taruta; Morinobu Endo
Journal:  Chem Rev       Date:  2014-04-10       Impact factor: 60.622

2.  Determinants of the thrombogenic potential of multiwalled carbon nanotubes.

Authors:  Andrew R Burke; Ravi N Singh; David L Carroll; John D Owen; Nancy D Kock; Ralph D'Agostino; Frank M Torti; Suzy V Torti
Journal:  Biomaterials       Date:  2011-06-12       Impact factor: 12.479

Review 3.  Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines.

Authors:  Marina A Dobrovolskaia; Scott E McNeil
Journal:  J Control Release       Date:  2013-06-03       Impact factor: 9.776

4.  Functional effects of nanoparticle exposure on Calu-3 airway epithelial cells.

Authors:  Amiraj Banga; Frank A Witzmann; Horia I Petrache; Bonnie L Blazer-Yost
Journal:  Cell Physiol Biochem       Date:  2012-03-01

5.  Nanoparticle size and surface charge determine effects of PAMAM dendrimers on human platelets in vitro.

Authors:  Marina A Dobrovolskaia; Anil K Patri; Jan Simak; Jennifer B Hall; Jana Semberova; Silvia H De Paoli Lacerda; Scott E McNeil
Journal:  Mol Pharm       Date:  2011-11-10       Impact factor: 4.939

6.  Thrombospondin-1 mediates multi-walled carbon nanotube induced impairment of arteriolar dilation.

Authors:  W Kyle Mandler; Timothy R Nurkiewicz; Dale W Porter; I Mark Olfert
Journal:  Nanotoxicology       Date:  2017-01-11       Impact factor: 5.913

Review 7.  Nanoparticles and the blood coagulation system. Part II: safety concerns.

Authors:  Anna N Ilinskaya; Marina A Dobrovolskaia
Journal:  Nanomedicine (Lond)       Date:  2013-06       Impact factor: 5.307

8.  Immunocompatibility of a new dual modality contrast agent based on radiolabeled iron-oxide nanoparticles.

Authors:  Maria-Argyro Karageorgou; Dimosthenis Stamopoulos
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

9.  The use of quartz crystal microbalance with dissipation (QCM-D) for studying nanoparticle-induced platelet aggregation.

Authors:  Maria Jose Santos-Martinez; Iwona Inkielewicz-Stepniak; Carlos Medina; Kamil Rahme; Deirdre M D'Arcy; Daniel Fox; Justin D Holmes; Hongzhou Zhang; Marek Witold Radomski
Journal:  Int J Nanomedicine       Date:  2012-01-13

10.  Amorphous silica nanoparticles aggregate human platelets: potential implications for vascular homeostasis.

Authors:  J Jose Corbalan; Carlos Medina; Adam Jacoby; Tadeusz Malinski; Marek W Radomski
Journal:  Int J Nanomedicine       Date:  2012-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.